Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug;120(8):13321-13329.
doi: 10.1002/jcb.28606. Epub 2019 Mar 19.

FKBP12: A partner of Snx10 required for vesicular trafficking in osteoclasts

Affiliations

FKBP12: A partner of Snx10 required for vesicular trafficking in osteoclasts

Ricardo A Battaglino et al. J Cell Biochem. 2019 Aug.

Abstract

Osteoclasts employ highly specialized intracellular trafficking controls for bone resorption and organelle homeostasis. The sorting nexin Snx10 is a (Phosphatidylinositol 3-phosphate) PI3P-binding protein, which localizes to osteoclast early endosomes. Osteoclasts from humans and mice lacking functional Snx10 are severely dysfunctional. They show marked impairments in endocytosis, extracellular acidification, ruffled border formation, and bone resorption, suggesting that Snx10 regulates membrane trafficking. To better understand how SNx10 regulates vesicular formation and trafficking in osteoclasts, we set out on a search for Snx10 partners. We performed a yeast two-hybrid screening and identified FKBP12. FKBP12 is expressed in receptor activator of nuclear factor kB ligand-stimulated RAW264.7 monocytes, coimmunoprecipitates with Snx10, and colocalizes with Snx10 in osteoclasts. We also found that FKBP12, Snx10, and early endosome antigen 1 (EEA1) are present in the same subcellular fractions obtained by centrifugation in sucrose gradients, which confirms localization of FKBP12 to early endosomes. Taken together, these results indicate that Snx10 and FKBP12 are partners and suggest that Snx10 and FKBP12 are involved in the regulation of endosome/lysosome homeostasis via the synthesis. These findings may suggest novel therapeutic approaches to control bone loss by targeting essential steps in osteoclast membrane trafficking.

Keywords: osteoclast; resorption; vesicular trafficking.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Y2H screening identifies FKBP12 as a partner of Snx10
The Predicted Biological Score (PBS) indicates interaction reliability and is primarily based on the comparison between the number of independent prey fragments found for an interaction and the chance of finding them at random (background noise). A PBS of A indicates the highest confidence. FKBP12 had 9 hits representing 3 independent clones: 1. Clone 15-641 (4 hits), 2. Clone 21-451 (2 hits) and 3. Clone 20-477 (3 hits). These numbers indicate the position of the 5p and 3p prey fragment ends, relative to the position of the ATG start codon (A=0). The degree of identity of all these fragments relative to the reference gene (FKBP12) is 100%.
Figure 2:
Figure 2:. FKBP12 and Snx10 are expressed in the same (lighter) sucrose gradient fractions.
Collected gradient fractions 1–12 of differentiated RAW264.7 cells were analyzed by SDS-PAGE and Western blotting for the distribution of organelle markers: early endosome antigen 1 (EEA1; EE marker), FKBP12 and Snx10. Fractions 1-3 contained the majority of the FKBP12 signal.
Figure 3.
Figure 3.. FKBP12 and Snx10 coprecipitate in osteoclast protein extracts
FKBP12 is expressed in unstimulated and RANKL-stimulated RAW264.7 cells (2a). Snx10 interacts with FKBP12 in RANKL-stimulated RAW264.7 cells (2b). Immunoprecipitation was done using an α-FKBP12 antibody. Immunoprecipitates were subjected to western blot analysis using an α-Snx10 antibody. The black arrow (2b) indicates a 25KD band corresponding to Snx10.
Figure 4.
Figure 4.. Immunofluorescent analysis confirms of Snx10 and FKBP12 co-localize to osteoclasts
RANKL and M-CSF stimulated mouse bone marrow mononuclear cells were fixed and stained with Snx10 (orange) and FKBP12 (green) antibodies. DAPI staining indicate nucleus. The superimposed image (overlay) indicates that both proteins colocalize to endosomes.

Similar articles

Cited by

References

    1. Caraveo G, Soste M, Cappelleti V, Fanning S, van Rossum DB, Whitesell L, Huang Y, Chung CY, Baru V, Zaichick S, Picotti P, Lindquist S. 2017. FKBP12 contributes to alpha-synuclein toxicity by regulating the calcineurin-dependent phosphoproteome. Proc Natl Acad Sci U S A 114:E11313–E11322. - PMC - PubMed
    1. Chen J, Long F. 2018. mTOR signaling in skeletal development and disease. Bone Res 6:1. - PMC - PubMed
    1. Chen X, Wang Z, Duan N, Zhu G, Schwarz EM, Xie C. 2018. Osteoblast-osteoclast interactions. Connect Tissue Res 59:99–107. - PMC - PubMed
    1. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu K, Xu K, Strathearn KE, Liu F, Cao S, Caldwell KA, Caldwell GA, Marsischky G, Kolodner RD, Labaer J, Rochet JC, Bonini NM, Lindquist S. 2006. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson’s models. Science 313:324–8. - PMC - PubMed
    1. Coxon FP, Taylor A. 2008. Vesicular trafficking in osteoclasts. Semin Cell Dev Biol 19:424–33. - PubMed

Publication types